Literature DB >> 2740146

The neuroprotective actions of a calcium channel antagonist, flunarizine, in the infant rat.

A J Gunn1, T Mydlar, L Bennet, R L Faull, S Gorter, C Cook, B M Johnston, P D Gluckman.   

Abstract

One postulated final common pathway leading to neuronal death after hypoxic-ischemic insults is an increase in intracellular calcium concentrations. We examined the effect of pretreatment with flunarizine, a calcium channel antagonist known to pass the blood brain barrier, on the behavioral and histologic changes after an hypoxic-ischemic insult in the infant rat. The 21-d-old rats were subjected to unilateral carotid ligation, then to 2 h of hypoxia. They were pretreated with either flunarizine (30 mg/kg, intraperitoneally) or with an equal volume of diluent. After 5 days of observation they were killed for histology. Acute behavioral abnormalities were observed in more controls than treatment animals, 52 vs 11% (p less than 0.002). Cerebral injury was almost entirely confined to the ligated side and was significantly worse in the control rats. Full thickness cortical infarction was noted in 56% of controls (n = 27) vs 4% of flunarizine-treated rats (n = 24), (p less than 0.001). Mean and maximum damage scores for all areas assessed including cortex, corpus striatum, thalamus, amygdala, and hippocampus were improved markedly in treatment rats (p less than 0.005). These observations confirm that flunarizine, when given prophylactically, has a neuroprotective effect against hypoxic-ischemic injury in the developing brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2740146     DOI: 10.1203/00006450-198906000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Microwave-enhanced silver staining of degenerating neuronal processes.

Authors:  B Van Deuren; J Van Reempts; M Borgers
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Ultrastructural changes in the blood-brain barrier in rats after treatment with nimodipine and flunarizine. A comparison.

Authors:  M Zumkeller; H Dietz
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

Review 3.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 4.  Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy.

Authors:  Makoto Nabetani; Haruo Shintaku; Takashi Hamazaki
Journal:  Pediatr Res       Date:  2017-11-08       Impact factor: 3.756

Review 5.  Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration.

Authors:  Natalia N Nalivaeva; Anthony J Turner; Igor A Zhuravin
Journal:  Front Neurosci       Date:  2018-11-19       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.